Allergen-specific immunotherapy and COVID-19: What happened?
Allergol. immunopatol
; 51(2): 148-150, 01 mar. 2023. graf
Article
in English
| IBECS
| ID: ibc-216817
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
ABSTRACT
Background:
The COVID-19 infection played a key role in the discontinuation of patient treatment, such as allergen-specific immunotherapy, in chronic diseases.Objectives:
We conducted a retrospective observational study at Verona University Hospital, Verona, Italy, to assess the level of adherence to sublingual immunotherapy (SLIT) in patients affected by allergic rhinitis and mild asthma. Materials andMethods:
We compared and analysed data related to first prescription and collection of 5-grass-pollen 300-index of reactivity (IR) SLIT and tablet lyophilisate, containing 75,000 standardized quality tablet units (SQ-T) allergen extract of grass-pollen from Phleum pratense L, for the five-year period 2017-2021.In particular we considered the group of naïve patients from 2017 who completed pre-COVID treatment (2017-2019) and the group of naïve patients from 2019 who completed treatment during the COVID period (2019-2021). The significance test used was Students t-test, and P ˂ 0.05 was considered as statistically significant.Results:
In the three-year period 2017-2019, 264 naïve patients began treatment in 2017, of these 181 continued in 2018, 135 continued in 2019. Instead, for the period 20172019, there were 226 naïve patients in 2019; of these 139 continued in 2020, and 102 in 2021.Conclusions:
COVID-19 did not seem to influence adherence to SLIT, which declined independently even in during the pre-pandemic 3-year period (AU)
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Asthma
/
Desensitization, Immunologic
/
Coronavirus Infections
/
Pandemics
/
Rhinitis, Allergic
Limits:
Humans
Language:
English
Journal:
Allergol. immunopatol
Year:
2023
Document type:
Article
Institution/Affiliation country:
University of Messina/Italy
/
University of Verona/Italy
/
Verona University Hospital/Italy